Bienstar Wellness Corp., an integrative mental health company specializing in psychedelic medicine with core operations in Latin America, has entered into a binding letter of intent to acquire 100% of BRC Saude Mental E Terapias Assistidas Ltda., a Brazilian psychedelic institution specialized in ibogaine treatment for substance abuse. Terms of the deal were not disclosed.
Brazil is the largest market in Latin America, with a population of 215 million. Ketamine and ibogaine substances are legal for medical use in psychotherapies in the South American country.
